Genetic susceptibility to lung cancer
Haruhiko Sugimura1, Hong Tao,1 Masaya Suzuki1, Hiroki Mori1, Masaru Tsuboi1, Shun Matsuura2, Masanori Goto1, Kazuya Shinmura1, Takachika Ozawa3, Fumihiko Tanioka4, Naomi Sato5, Yoshitaka Matsushima6, Shinji Kageyama1, Kazuhito Funai7, Pei-Hsin Chou8, Tomonari Matsuda8
1
Department of Pathology, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan, 2Department of Pulmonary Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku,Hamamatsu, Shizuoka, 431-3192, Japan, 3Department of Pathology, Hamamatsu Medical Center, 328 Tomizuka-cho, Naka-ku, Hamamatsu, Shizuoka, 432-8580, Japan, 4Department of Pathology and Laboratory Medicine, Iwata City Hospital, 512-3 Okubo, Iwata, Shizuoka, 438-8550, Japan, 5Department of Clinical Nursing, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku,Hamamatsu, Shizuoka, 431-3192, Japan, 6Department of Chemistry, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku,Hamamatsu, Shizuoka, 431-3192, Japan, 7Department of Thoracic Surgery, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan, 8Research Center for Environmental Quality Management, Kyoto University, 1-2 Yumihama, Otsu, Shiga, 520-0811, Japan
TABLE OF CONTENTS
- 1. Abstract
- 2. Introduction
- 3. Candidate genes of lung cancer susceptibility
- 3.1. Carcinogen-activation genes
- 3.2. Carcinogen-detoxification genes
- 3.3. Repair gene polymorphism and lung cancer susceptibility
- 3.4. Oncogene and suppressor gene polymorphisms, and other genetic and epigenetic variations to modify lung Cancer susceptibility
- 4. The Era of genome-wide association study
- 5. Smoking behavior and lung cancer susceptibility
- 6. Exposure assessment and lung cancer susceptibility
- 7. Perspectives
- 8. Acknowledgements
- 9. References
1. ABSTRACT
Lung cancer is a highly environmental disease, but cancer researchers have long been interested in investigating genetic susceptibility to lung cancer. This paper is a historical review and provides updated perspectives on lung cancer susceptibility research. The recent introduction of easier genotyping methods and the availability of an almost complete human genome database facilitated the association study to thousands of cases and controls for millions of genetic markers. Discoveries in the field of behavior genetics, that is, the genetic aspects of smoking behavior and nicotine addiction, unexpectedly indicated that polymorphisms in the human central nervous system play an important role in eventually leading to lung cancer. These findings were achieved by using comprehensive approaches, such as a genome, transcriptome, or proteome approach, and the studies were often conducted without a hypothesis. Another-omics approach, the "adductome" or "exposome" approach to how life style information can be integrated into the framework of genetic association studies, has recently emerged. These new paradigms will influence the area of lung cancer risk evaluation in genome cohort studies.
[Frontiers in Bioscience 14, 2009-2009, January 1, 2009]

[Frontiers in Bioscience 14, 2009-2009, January 1, 2009]
|
|
Alternatively spliced tissue factor pathway inhibitor: Functional Implications
Alan E. Mast1
1 Blood Research Institute, Blood Center of Wisconsin, Milwaukee, WI, Department of Cell Biology, Neurobiology and Anatomy, Medical College of Wisconsin, Milwaukee, WI
TABLE OF CONTENTS
- 1. Abstract
- 2. Introduction
- 3. Alternatively spliced forms of TFPI
- 4. Evolution of alternatively spliced forms of TFPI
- 5. Tissue expression of alternatively spliced forms of TFPI
- 6. Perspective: Potential for differential function of alternatively spliced forms of TFPI
- 7. References
1. ABSTRACT
Tissue factor pathway inhibitor (TFPI) is a factor Xa dependent inhibitor of tissue factor initiated blood coagulation. In recent years several alternatively spliced forms of TFPI have been identified. These alternatively spliced forms have different C-terminal regions and have different mechanisms for association with cell surfaces. They are differentially expressed in human and mouse tissues and may have distinct physiological functions.
|